Skip to main content

2018 Disruptor 50: No. 7 23andMe

In 2015 the FDA finally gave 23andMe the green light to market genetic reports on an individual's risk for a handful of diseases. Now the company is making great strides in medical research.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.